TAUZIN STRATEGIC NETWORKS

View full entity profile (contributions, contracts, SEC) →

Lobbying Income

$12.9M

Filings

436

Unique Clients

Active Period

2010–2026

Lobbying Income by Year

Registrant-reported income from clients on LDA filings

Year	Lobbying Income	Filings	Clients
2026	$217,500	6	2
2025	$650,000	13	3
2024	$530,000	10	3
2023	$570,000	12	3
2022	$570,000	13	3
2021	$805,000	26	9
2020	$1,265,000	47	12
2019	$1,290,000	69	14
2018	$1,380,000	45	12
2017	$910,000	47	12
2016	$920,000	46	10
2015	$880,000	41	9
2014	$1,110,000	28	5
2013	$810,000	17	4
2012	$530,000	10	3
2011	$510,000	5	1
2010	—	1	1

Top Clients

Largest clients by registrant-reported income

Client	Reported Income	Filings	Period
PARTNERSHIP FOR QUALITY HOME HEALTHCARE	$3,710,000	59	2010–2024
CONOCOPHILLIPS	$2,200,000	41	2016–2025
FOX REHABILITATION	$1,800,000	37	2017–2026
EMD SERONO	$1,560,000	27	2012–2016
CORNING INC	$510,000	24	2015–2019
TAUZIN CONSULTANTS (ON BEHALF OF T-MOBILE USA, INC.)	$505,000	27	2015–2021
CAPTURERX	$500,000	12	2018–2020
TAUZIN CONSULTANTS (ON BEHALF OF ST. CHARLES PARISH)	$465,000	27	2016–2021
TAUZIN CONSULTANTS (ON BEHALF OF SORRENTO THERAPEUTICS, INC)	$240,000	15	2019–2021
TAUZIN CONSULTANTS (ON BEHALF OF AVALON GLOBOCARE CORPORATION)	$230,000	18	2017–2021
TAUZIN CONSULTANTS (ON BEHALF OF SCILEX HOLDING COMPANY)	$220,000	14	2019–2021
RAZORMETRICS	$217,500	8	2025–2026
TAUZIN CONSULTANTS (ON BEHALF OF CENTURYTEL SERVICES GROUP, LLC)	$200,000	22	2015–2019
ENDO PHARMACEUTICALS INC	$180,000	6	2012–2013
LHC GROUP INC.	$155,000	17	2014–2017
TAUZIN CONSULTANTS (ON BEHALF OF APPSENTIAL, LLC)	$125,000	7	2019–2020
TAUZIN CONSULTANTS (ON BEHALF OF ST BERNARD PARISH COUNCIL)	$100,000	8	2017–2018
TAUZIN CONSULTANTS (ON BEHALF OF COQUI RADIOPHARMACEUTICALS, CORP.)	$20,000	4	2015
TAUZIN CONSULTANTS (ON BEHALF TED JONES LAW, ON BEHALF OF ST. BERNARD PORT)	$10,000	7	2016–2018
TAUZIN CONSULTANTS (ON BEHALF OF GREEN COOLING TOWER OPERATIONS LLC)	—	32	2014–2021
TAUZIN CONSULTANTS (ON BEHALF OF STONE CLINICAL LABORATORIES LLC )	—	12	2019–2020
TAUZIN CONSULTANTS (ON BEHALF OF CURE CARE)	—	12	2013–2015

Government Bodies Lobbied

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
SENATE	255
HOUSE OF REPRESENTATIVES	252
Centers For Medicare and Medicaid Services (CMS)	55
Health & Human Services, Dept of (HHS)	55
Army, Dept of (Corps of Engineers)	21
Energy, Dept of	19
Food & Drug Administration (FDA)	15
On-Site Inspection Agency	14
Federal Emergency Management Agency (FEMA)	7
Agriculture, Dept of (USDA)	3
Defense, Dept of (DOD)	3
Office of the Vice President of the United States	3
Executive Office of the President (EOP)	2
Office of Natl Drug Control Policy (NDCP)	2
U.S. Agency for International Development (USAID)	2
Veterans Affairs, Dept of (VA)	2
Congressional Budget Office (CBO)	1
Tennessee Valley Authority (TVA)	1
U.S. Trade Representative (USTR)	1
White House Office	1

Top Issues Lobbied

Most frequently reported lobbying issues

Issue Code	Description	Reports
Health Issues	Health Issues	200
Medicare/Medicaid	Medicare/Medicaid	118
Telecommunications	Telecommunications	48
Communications/Broadcasting/Radio/TV	Communications/Broadcasting/Radio/TV	48
Transportation	Transportation	44
Environment/Superfund	Environment/Superfund	35
Disaster Planning/Emergencies	Disaster Planning/Emergencies	35
Budget/Appropriations	Budget/Appropriations	31
Family issues/Abortion/Adoption	Family issues/Abortion/Adoption	26
Pharmacy	Pharmacy	25
Taxation/Internal Revenue Code	Taxation/Internal Revenue Code	24
Energy/Nuclear	Energy/Nuclear	24
Marine/Maritime/Boating/Fisheries	Marine/Maritime/Boating/Fisheries	22
Financial Institutions/Investments/Securities	Financial Institutions/Investments/Securities	22
Fuel/Gas/Oil	Fuel/Gas/Oil	12
Veterans	Veterans	11
Government Issues	Government Issues	6
Animals	Animals	2
Real Estate/Land Use/Conservation	Real Estate/Land Use/Conservation	2
Economics/Economic Development	Economics/Economic Development	2

Bills Explicitly Cited (25)

Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded

S. 1895116th Congress

Lower Health Care Costs Act

2020 · fourth_quarter · Client: TAUZIN CONSULTANTS (ON BEHALF OF SCILEX HOLDING COMPANY)

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to fair competition, the generic drug market, drug costs, pain management, S.1895, the Lower Health Care Costs Act; Patient Affordability Value and Efficiency Act (bill number TBD).

Client expense: — · Firm income: $20,000

Matched citations: S.1895

S. 1895116th Congress

Lower Health Care Costs Act

2020 · fourth_quarter · Client: TAUZIN CONSULTANTS (ON BEHALF OF SCILEX HOLDING COMPANY)

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to fair competition, the generic drug market, drug costs, S.1895, the Lower Health Care Costs Act; Patient Affordability Value and Efficiency Act (bill number TBD). Issues related to COVID-19.

Client expense: — · Firm income: $20,000

Matched citations: S.1895

S. 1895116th Congress

Lower Health Care Costs Act

2020 · fourth_quarter · Client: TAUZIN CONSULTANTS (ON BEHALF OF SORRENTO THERAPEUTICS, INC)

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to fair competition, the generic drug market, drug costs, pain management, S.1895, the Lower Health Care Costs Act; Patient Affordability Value and Efficiency Act. Also issues related to COVID-19.

Client expense: — · Firm income: $50,000

Matched citations: S.1895

S. 1895116th Congress

Lower Health Care Costs Act

2020 · fourth_quarter · Client: TAUZIN CONSULTANTS (ON BEHALF OF SORRENTO THERAPEUTICS, INC)

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to fair competition, the generic drug market, drug costs, S.1895, the Lower Health Care Costs Act; Patient Affordability Value and Efficiency Act (bill number TBD).

Client expense: — · Firm income: $50,000

Matched citations: S.1895

Show 21 more cited filings

S. 1895116th Congress

Lower Health Care Costs Act

2020 · third_quarter · Client: TAUZIN CONSULTANTS (ON BEHALF OF SCILEX HOLDING COMPANY)

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to fair competition, the generic drug market, drug costs, pain management, S.1895, the Lower Health Care Costs Act; Patient Affordability Value and Efficiency Act (bill number TBD).

Client expense: — · Firm income: $30,000

Matched citations: S.1895

S. 1895116th Congress

Lower Health Care Costs Act

2020 · third_quarter · Client: TAUZIN CONSULTANTS (ON BEHALF OF SCILEX HOLDING COMPANY)

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to fair competition, the generic drug market, drug costs, S.1895, the Lower Health Care Costs Act; Patient Affordability Value and Efficiency Act (bill number TBD). Issues related to COVID-19.

Client expense: — · Firm income: $30,000

Matched citations: S.1895

S. 1895116th Congress

Lower Health Care Costs Act

2020 · third_quarter · Client: TAUZIN CONSULTANTS (ON BEHALF OF SORRENTO THERAPEUTICS, INC)

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to fair competition, the generic drug market, drug costs, S.1895, the Lower Health Care Costs Act; Patient Affordability Value and Efficiency Act (bill number TBD).

Client expense: — · Firm income: $20,000

Matched citations: S.1895

S. 1895116th Congress

Lower Health Care Costs Act

2020 · third_quarter · Client: TAUZIN CONSULTANTS (ON BEHALF OF SORRENTO THERAPEUTICS, INC)

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to fair competition, the generic drug market, drug costs, pain management, S.1895, the Lower Health Care Costs Act; Patient Affordability Value and Efficiency Act. Also issues related to COVID-19.

Client expense: — · Firm income: $20,000

Matched citations: S.1895

S. 1895116th Congress

Lower Health Care Costs Act

2020 · second_quarter · Client: TAUZIN CONSULTANTS (ON BEHALF OF SCILEX HOLDING COMPANY)

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to fair competition, the generic drug market, drug costs, S.1895, the Lower Health Care Costs Act; Patient Affordability Value and Efficiency Act (bill number TBD). Issues related to COVID-19.

Client expense: — · Firm income: $50,000

Matched citations: S.1895

S. 1895116th Congress

Lower Health Care Costs Act

2020 · second_quarter · Client: TAUZIN CONSULTANTS (ON BEHALF OF SCILEX HOLDING COMPANY)

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to fair competition, the generic drug market, drug costs, pain management, S.1895, the Lower Health Care Costs Act; Patient Affordability Value and Efficiency Act (bill number TBD).

Client expense: — · Firm income: $50,000

Matched citations: S.1895

S. 1895116th Congress

Lower Health Care Costs Act

2020 · second_quarter · Client: TAUZIN CONSULTANTS (ON BEHALF OF SORRENTO THERAPEUTICS, INC)

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to fair competition, the generic drug market, drug costs, pain management, S.1895, the Lower Health Care Costs Act; Patient Affordability Value and Efficiency Act. Also issues related to COVID-19.

Client expense: — · Firm income: $30,000

Matched citations: S.1895

S. 1895116th Congress

Lower Health Care Costs Act

2020 · second_quarter · Client: TAUZIN CONSULTANTS (ON BEHALF OF SORRENTO THERAPEUTICS, INC)

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to fair competition, the generic drug market, drug costs, S.1895, the Lower Health Care Costs Act; Patient Affordability Value and Efficiency Act (bill number TBD).

Client expense: — · Firm income: $30,000

Matched citations: S.1895

S. 1895116th Congress

Lower Health Care Costs Act

2020 · first_quarter · Client: TAUZIN CONSULTANTS (ON BEHALF OF SCILEX HOLDING COMPANY)

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to fair competition, the generic drug market, drug costs, pain management, S.1895, the Lower Health Care Costs Act; Patient Affordability Value and Efficiency Act (bill number TBD).

Client expense: — · Firm income: —

Matched citations: S.1895

S. 1895116th Congress

Lower Health Care Costs Act

2020 · first_quarter · Client: TAUZIN CONSULTANTS (ON BEHALF OF SCILEX HOLDING COMPANY)

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to fair competition, the generic drug market, drug costs, S.1895, the Lower Health Care Costs Act; Patient Affordability Value and Efficiency Act (bill number TBD).

Client expense: — · Firm income: —

Matched citations: S.1895

S. 1895116th Congress

Lower Health Care Costs Act

2020 · first_quarter · Client: TAUZIN CONSULTANTS (ON BEHALF OF SORRENTO THERAPEUTICS, INC)

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to fair competition, the generic drug market, drug costs, S.1895, the Lower Health Care Costs Act; Patient Affordability Value and Efficiency Act (bill number TBD).

Client expense: — · Firm income: $20,000

Matched citations: S.1895

S. 1895116th Congress

Lower Health Care Costs Act

2020 · first_quarter · Client: TAUZIN CONSULTANTS (ON BEHALF OF SORRENTO THERAPEUTICS, INC)

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to fair competition, the generic drug market, drug costs, pain management, S.1895, the Lower Health Care Costs Act; Patient Affordability Value and Efficiency Act

Client expense: — · Firm income: $20,000

Matched citations: S.1895

S. 1895116th Congress

Lower Health Care Costs Act

2019 · fourth_quarter · Client: TAUZIN CONSULTANTS (ON BEHALF OF SCILEX HOLDING COMPANY)

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to fair competition, the generic drug market, drug costs, pain management, S.1895, the Lower Health Care Costs Act; Patient Affordability Value and Efficiency Act (bill number TBD).

Client expense: — · Firm income: —

Matched citations: S.1895

S. 1895116th Congress

Lower Health Care Costs Act

2019 · fourth_quarter · Client: TAUZIN CONSULTANTS (ON BEHALF OF SCILEX HOLDING COMPANY)

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to fair competition, the generic drug market, drug costs, S.1895, the Lower Health Care Costs Act; Patient Affordability Value and Efficiency Act (bill number TBD).

Client expense: — · Firm income: —

Matched citations: S.1895

S. 1895116th Congress

Lower Health Care Costs Act

2019 · fourth_quarter · Client: TAUZIN CONSULTANTS (ON BEHALF OF SORRENTO THERAPEUTICS, INC)

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to fair competition, the generic drug market, drug costs, pain management, S.1895, the Lower Health Care Costs Act; Patient Affordability Value and Efficiency Act

Client expense: — · Firm income: $10,000

Matched citations: S.1895

S. 1895116th Congress

Lower Health Care Costs Act

2019 · fourth_quarter · Client: TAUZIN CONSULTANTS (ON BEHALF OF SORRENTO THERAPEUTICS, INC)

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to fair competition, the generic drug market, drug costs, pain management, S.1895, the Lower Health Care Costs Act; Patient Affordability Value and Efficiency Act (bill number TBD).

Client expense: — · Firm income: $10,000

Matched citations: S.1895

S. 1895116th Congress

Lower Health Care Costs Act

2019 · fourth_quarter · Client: TAUZIN CONSULTANTS (ON BEHALF OF SCILEX HOLDING COMPANY)

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to fair competition, the generic drug market, drug costs, pain management, S.1895, the Lower Health Care Costs Act; Patient Affordability Value and Efficiency Act (bill number TBD).

Client expense: — · Firm income: $20,000

Matched citations: S.1895

S. 1895116th Congress

Lower Health Care Costs Act

2019 · fourth_quarter · Client: TAUZIN CONSULTANTS (ON BEHALF OF SCILEX HOLDING COMPANY)

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to fair competition, the generic drug market, drug costs, pain management, S.1895, the Lower Health Care Costs Act; Patient Affordability Value and Efficiency Act (bill number TBD).

Client expense: — · Firm income: $20,000

Matched citations: S.1895

S. 1895116th Congress

Lower Health Care Costs Act

2019 · fourth_quarter · Client: TAUZIN CONSULTANTS (ON BEHALF OF SORRENTO THERAPEUTICS, INC)

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to fair competition, the generic drug market, drug costs, pain management, S.1895, the Lower Health Care Costs Act; Patient Affordability Value and Efficiency Act (bill number TBD).

Client expense: — · Firm income: $10,000

Matched citations: S.1895

S. 1895116th Congress

Lower Health Care Costs Act

2019 · fourth_quarter · Client: TAUZIN CONSULTANTS (ON BEHALF OF SORRENTO THERAPEUTICS, INC)

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to fair competition, the generic drug market, drug costs, pain management, S.1895, the Lower Health Care Costs Act; Patient Affordability Value and Efficiency Act

Client expense: — · Firm income: $10,000

Matched citations: S.1895

S. 1895116th Congress

Lower Health Care Costs Act

2019 · third_quarter · Client: TAUZIN CONSULTANTS (ON BEHALF OF SCILEX HOLDING COMPANY)

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to fair competition, the generic drug market, drug costs, pain management, S.1895, the Lower Health Care Costs Act; Patient Affordability Value and Efficiency Act (bill number TBD).

Client expense: — · Firm income: $20,000

Matched citations: S.1895

Source: Senate LDA

TAUZIN STRATEGIC NETWORKS — Lobbying Disclosure | Poliscope